Media coverage of Fixel Institute announcement
See media highlights stemming from Jan. 18's Norman Fixel Institute for Neurological Diseases at UF Health gift announcement.
Posts tagged as
Todd Golde
UF and UF Health announce $20 million gift from Lauren and Lee Fixel Foundation
Funds will help launch institute at UF Health for Parkinson’s and other neurodegenerative diseases.
Alzheimer’s disease: The right drug, the right time
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
UF-led consortium aims to accelerate Alzheimer’s research and treatment
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Research!America Town Hall encourages scientists to work with policymakers
MBI director Dr. Todd Golde facilitated a Research!America Town Hall panel including Mary Woolley, retired U.S. Rep. John Edward Porter, Dr. Stephen Sugrue and Dr. David Norton.
UF neurosurgery and neurology departments team up for interdisciplinary NIH grant
Five-year National Institutes of Health Research Education Program, or R25, grant supports residents’ research education activities and academic career development.
MBI Director Dr. Todd Golde discusses dementia
Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
The use of rodent models to study neurodegenerative disease
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.
MBI director Dr. Todd Golde hosts UF Eye Opener Discovery Breakfast
Dr. Golde discussed neuromedicine research on campus — from Alzheimer's disease to age-related memory loss to brain cancer.
MBI researchers identify potential strategy to treat Alzheimer’s disease
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
